Patents by Inventor Bin Zheng

Bin Zheng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240133606
    Abstract: The present disclosure provides a control method, apparatus, and device for a compressor, a storage medium, and a refrigerator system. The control method includes: obtaining an electrical parameter, a return air parameter, and a first frequency of the compressor during operation of the compressor; determining a first fitting formula corresponding to the first frequency; obtaining an exhaust pressure by inputting the electrical parameter and the return air parameter into the first fitting formula for calculation; and controlling the compressor based on the exhaust pressure. In this way, the pressure sensor disposed on an exhaust side of an air conditioner can be omitted, hence cost is saved; or for the air conditioner with the pressure sensor on the exhaust side, the above manner for calculation can be an alternative to obtaining the exhaust pressure, which ensures a user's normal use and thus improves the user experience.
    Type: Application
    Filed: September 28, 2021
    Publication date: April 25, 2024
    Inventors: Fangcheng GUO, Yunxiao DING, Chunyuan ZHENG, Bin LUO, Bao YUE
  • Patent number: 11946073
    Abstract: A method for non-enzymatic 3D culture and amplification of mesenchymal stem cells (MSCs) includes the followings steps: preparing PLGA porous microspheres; preparing a PLGA-PEG-PLGA thermosensitive coating microcarrier; culturing and amplifying MSCs; and performing non-enzymatic separation of MSCs, including reducing a culture temperature to below a critical phase transition temperature, and centrifuging a culture medium to collect stem cells. The present invention adopts the method for non-enzymatic 3D culture and amplification of MSCs, wherein the PLGA porous microspheres are used as a cell culture microcarrier scaffold and the thermosensitive hydrogel PLGA-PEG-PLGA is coated on surfaces of such microspheres, without needing additional enzymolysis process, thus efficiently amplifying the stem cells.
    Type: Grant
    Filed: May 8, 2022
    Date of Patent: April 2, 2024
    Assignees: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin Zheng, Yulin Cao, Wenchang Peng, Shixiang Cheng
  • Patent number: 11945775
    Abstract: A stable dispersant and an application thereof in preparing copolymer polyols, the preparation method for the stable dispersant including the steps of 1) contacting a polyol with a dianhydride compound for reaction so as to prepare an adduct; 2) performing a ring-opening addition reaction on the adduct obtained in step 1) and an epoxy compound to prepare a stable dispersant; the dianhydride compound does not contain a double bond that may copolymerize with an olefinically unsaturated monomer, while the epoxy compound contains a double bond that may copolymerize with an olefinically unsaturated monomer, the polyol is a polyester polyol and/or a polyether polyol, preferably being a polyether polyol. The stable dispersant obtained by means of the described preparation method has a multi-active site anchoring function, and is applied to the synthesis of copolymer polyols to obtain copolymer polyols having relatively uniform particle size.
    Type: Grant
    Filed: December 26, 2018
    Date of Patent: April 2, 2024
    Assignee: WANHUA CHEMICAL GROUP CO., LTD.
    Inventors: Fuguo Li, Yang Liu, Changxun Ju, Bin Liu, Chengqun Qin, Xunkun Wu, Jing Li, Bing Zheng, Lunpeng Wang
  • Publication number: 20240091282
    Abstract: A probiotic microcapsule for the treatment of reproductive tract infection and a preparation method and application thereof are provided. The probiotic microcapsule is obtained by coating probiotics with the coating material. The probiotics include one or several of Lactobacillus acidophilus, Lactobacillus rhamnosus, Lactobacillus fermentum, Lactobacillus reuteri, Lactobacillus crimpus, Lactobacillus brevis, Lactobacillus salivary, Lactobacillus plantarum, Lactobacillus acidophilus, and Lactobacillus bulgaricus. As probiotics screened in reproductive tract, it has high safety; It endows probiotics with adhesion function to ensure their effect in the reproductive tract; It overcomes the defects of current antibiotic therapy; It is expected to be used in a variety of reproductive tract infectious diseases.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 21, 2024
    Applicants: Tangyi Biomedical (Tianjin) Co., Ltd., Tangyi Holding (Shenzhen) Co., Ltd.
    Inventors: Bin ZHENG, Qinglu GUO, Yulin CAO, Shixiang CHENG, Zhihui BAI
  • Publication number: 20240091514
    Abstract: A transdermal double-layer microneedle based on hydrogen producing probiotics and its preparation method and application thereof are provided. The transdermal double-layer microneedle consists of a needle body and a backing layer. The raw material of the needle body includes hyaluronic acid and hyaluronidase. The raw material of the backing layer includes methacrylate anhydride gelatin and silk fibroin protein. The hydrogen producing bacteria are loaded in the microneedles, and the pore size of the matrix material is lower than the diameter of the probiotics, which will not lead to the leakage of bacteria and has high safety. Treatment of inflammatory skin diseases by gas has low side effects. The needle tip is loaded with hyaluronidase to increase the tissue space and improve the effect of gas treatment. It is expected to be used in psoriasis and other inflammatory skin diseases.
    Type: Application
    Filed: October 18, 2022
    Publication date: March 21, 2024
    Applicants: Tangyi Biomedical (Tianjin) Co., Ltd., Tangyi Holding (Shenzhen) Co., Ltd.
    Inventors: Bin ZHENG, Qinglu GUO, Yulin CAO, Shixiang CHENG, Zhihui BAI
  • Publication number: 20240094808
    Abstract: An eye-gaze tracking apparatus and a method of eye-gaze tracking. The eye-gaze tracking apparatus comprises: a plurality of foreground cameras each arranged to capture at least a portion of a target view area of a user; and an eye-gaze estimation module having at least one eye-gaze camera each arranged to capture an image an eye of the user, so as to estimate a position of a pupil of the eye based on the image of the eye; wherein each of the plurality of foreground cameras includes a field-of-view (FOV) being different from each other.
    Type: Application
    Filed: January 5, 2023
    Publication date: March 21, 2024
    Inventors: Hong FU, Bin Fu, Yang Zheng, Ruimin Li
  • Patent number: 11926787
    Abstract: A well cementing method is described for improving cementing quality by controlling the hydration heat of cement slurry. By controlling the degree and/or rate of hydration heat release from cement slurry, the method improves the hydration heat release during formation of cement with curing of cement slurry, improves the binding quality between the cement and the interfaces, and in turn improves the cementing quality at the open hole section and/or the overlap section. The cementing method improves cementing quality of oil and gas wells and reduces the risk of annular pressure.
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: March 12, 2024
    Assignees: PetroChina Company Limited, CNPC Engineering Technology R&D Company Limited
    Inventors: Shuoqiong Liu, Hua Zhang, Jianzhou Jin, Ming Xu, Yongjin Yu, Fengzhong Qi, Congfeng Qu, Hong Yue, Youcheng Zheng, Wei Li, Yong Ma, Youzhi Zheng, Zhao Huang, Jinping Yuan, Zhiwei Ding, Chongfeng Zhou, Chi Zhang, Zishuai Liu, Hongfei Ji, Yuchao Guo, Xiujian Xia, Yong Li, Jiyun Shen, Huiting Liu, Yusi Feng, Bin Lyu
  • Publication number: 20240066189
    Abstract: Disclosed is a high anticoagulation extracorporeal circulation tube, which include the following preparation methods: S1, firstly, aminating the surface of the tube by extrusion molding; S2, activating heparin groups by a direct coupling method; S3, heparinizing PVC or PC tubes; S4, then, using albumin, functionalized PEG which can react with amino groups, and phosphate to further surface modify the inner wall of heparinized PVC or PC tube to block the sites not modified by heparinization, so as to shield the adsorption of platelets and protein in blood on the inner wall. The application can produce a novel high anticoagulation extracorporeal circulation tube with low price and high biocompatibility, which expands the application in clinic.
    Type: Application
    Filed: September 20, 2022
    Publication date: February 29, 2024
    Applicant: Wenzhou Safety (Emergency) Research Institute, Tianjin University
    Inventors: Bin ZHENG, Haojun FAN, Bowen LI, Tingting HUA
  • Publication number: 20240066201
    Abstract: Disclosed is a high anticoagulation ECMO and extracorporeal circulation consumable, which include the following preparation methods: S1, aminating the surface of ECMO blood circulation device and extracorporeal circulation consumables; S2, activating heparin groups; S3, heparinizing the ECMO blood circulation device and extracorporeal circulation consumables; S4, modification of enhancer. The application can produce a novel high anticoagulation extracorporeal circulation tube with low price and high biocompatibility, which expands the application in clinic.
    Type: Application
    Filed: September 20, 2022
    Publication date: February 29, 2024
    Applicant: Wenzhou Safety (Emergency) Research Institute, Tianjin University
    Inventors: Bin ZHENG, Haojun FAN, Bowen LI, Tingting HUA
  • Patent number: 11917241
    Abstract: The present disclosure relates to an electronic device and its execution method and a computer-readable medium. An electronic device, comprising: a memory having instructions stored thereon; a processor configured to execute instructions stored on the memory to cause the electronic device to perform the following operations: analyzing an original video stream being played to determine start time and duration of a first video stream part to be replaced in the original video stream; retrieving a second video stream part with the same duration; playing the second video stream part in a front end at the determined start time to play the original video stream in a backend; and playing the original video stream in the front end after finishing playing the second video stream part.
    Type: Grant
    Filed: January 20, 2023
    Date of Patent: February 27, 2024
    Assignee: ARRIS ENTERPRISES LLC
    Inventors: Xiao-Song Huang, Hong-Bin Zhao, Hong-Chao Zheng
  • Patent number: 11890397
    Abstract: Disclosed is a high anticoagulation extracorporeal circulation tube, which include the following preparation methods: S1, firstly, aminating the surface of the tube by extrusion molding; S2, activating heparin groups by a direct coupling method; S3, heparinizing PVC or PC tubes; S4, then, using albumin, functionalized PEG which can react with amino groups, and phosphate to further surface modify the inner wall of heparinized PVC or PC tube to block the sites not modified by heparinization, so as to shield the adsorption of platelets and protein in blood on the inner wall. The application can produce a novel high anticoagulation extracorporeal circulation tube with low price and high biocompatibility, which expands the application in clinic.
    Type: Grant
    Filed: September 20, 2022
    Date of Patent: February 6, 2024
    Assignee: Wenzhou Safety (Emergency) Research Institute, Tianjin University
    Inventors: Bin Zheng, Haojun Fan, Bowen Li, Tingting Hua
  • Publication number: 20230416252
    Abstract: The present application generally relates to several processes for the preparation of (6R,10S)-10-{4-[5-chloro-2-(4-chloro-1H-1,2,3-triazol-1-yl)phenyl]-6-oxo-1(6H)-pyrimidinyl}-1-(difluoromethyl)-6-methyl-1,4,7,8,9,10-hexahydro-11,15-(metheno)pyrazolo[4,3-b][1,7]diazacyclotetradecin-5(6H)-one: Compound (I).
    Type: Application
    Filed: October 11, 2021
    Publication date: December 28, 2023
    Inventors: Subha MUKHERJEE, William P. GALLAGHER, Christopher Robert JAMISON, Carolyn S. WEI, Sergei KOLOTUCHIN, Amarjit SINGH, Nicolas CUNIERE, Chris SFOUGGATAKIS, Adrian ORTIZ, Steven R. WISNIEWSKI, Bin ZHENG, Helen Y. LUO, Sébastien François Emmanuel LEMAIRE, Cyril BEN HAÏM, Kostiantyn CHERNICHENKO, Diego Fernando Domenico BROGGINI, Simon Albert WAGSCHAL, Duy Chi Trung CAO, Karl REUTER, Björn SCHMALZBAUER, Philipp KOSCHKER, Martin D. EASTGATE, Dimitri SKLIAR, Alexander ZHDANKO, Christos XIOURAS, Matthew Penfield MOWER, Ngoc Duc TRAN, Ramdane RAHMANI, Xavier Jean-Marie JUSSEAU, Kiran MATCHA, Luca Alessandro PEREGO
  • Publication number: 20230403180
    Abstract: For communicably connecting with an opposing apparatus using VLANs on multiple communication pathways, communication addresses of the opposing apparatus and relay apparatuses located on the communication pathways are acquired. Used VLAN-IDs already being utilized for configuring other VLANs by the opposing apparatus and the relay apparatuses located on the communication pathways are acquired. A VLAN-ID that is not being utilized is identified based on the used VLAN-IDs that are already being utilized for configuring other VLANs by a local apparatus, the relay apparatuses, and the opposing apparatus. The identified VLAN-ID is used to set settings for communicably connecting the opposing apparatus and the relay apparatuses on a single communication pathway using a new VLAN.
    Type: Application
    Filed: May 31, 2023
    Publication date: December 14, 2023
    Applicant: NEC Corporation
    Inventor: Bin Zheng
  • Publication number: 20230383365
    Abstract: Provided herein are methods for treating cancer and for selecting a cancer treatment based on the expression of Stag2/3 proteins and/or the presence of mutations in the genes encoding Stag2/3 proteins.
    Type: Application
    Filed: May 25, 2023
    Publication date: November 30, 2023
    Applicant: The General Hospital Corporation
    Inventor: BIN ZHENG
  • Patent number: 11826461
    Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: November 28, 2023
    Assignees: TANGYI HOLDINGS (SHENZHEN) LIMITED, HEALTHINA STEM CELL INDUSTRY PLATFORM (TIANJIN) LIMITED
    Inventors: Bin Zheng, Yulin Cao, Bowen Li, Wei Sun, Shixiang Cheng
  • Patent number: 11793840
    Abstract: The present invention discloses a nano-armored single cell product, comprising a liposome and probiotics encapsulated by the liposome, wherein the probiotics are fermented to produce gamma-aminobutyric acid (GABA) that alleviates the activation of an inflammatory response in substantia nigra inducedin a MPTP induced PD model, thus mitigating an inflammatory injury to dopaminergic neurons in substantia nigra and having a neuroprotective effect; encapsulation of the probiotics by the liposome can protect the probiotics from strong acids and digestive enzymes in gastric acid.
    Type: Grant
    Filed: October 18, 2021
    Date of Patent: October 24, 2023
    Assignees: Tangyi Holdings(Shenzhen) Limited, Healthina Stem Cell Industry Platform (Tianjin) Limited
    Inventors: Bin Zheng, Yulin Cao, Wei Sun, Qinglu Guo, Shixiang Cheng
  • Publication number: 20230287352
    Abstract: A method for non-enzymatic 3D culture and amplification of mesenchymal stem cells (MSCs) includes the followings steps: preparing PLGA porous microspheres; preparing a PLGA-PEG-PLGA thermosensitive coating microcarrier; culturing and amplifying MSCs; and performing non-enzymatic separation of MSCs, including reducing a culture temperature to below a critical phase transition temperature, and centrifuging a culture medium to collect stem cells. The present invention adopts the method for non-enzymatic 3D culture and amplification of MSCs, wherein the PLGA porous microspheres are used as a cell culture microcarrier scaffold and the thermosensitive hydrogel PLGA-PEG-PLGA is coated on surfaces of such microspheres, without needing additional enzymolysis process, thus efficiently amplifying the stem cells.
    Type: Application
    Filed: May 8, 2022
    Publication date: September 14, 2023
    Applicants: Healthina Stem Cell Industry Platform (Tianjin) Limited, Tangyi Holdings(Shenzhen) Limited
    Inventors: Bin ZHENG, Yulin CAO, Wenchang PENG, Shixiang CHENG
  • Patent number: 11751691
    Abstract: Embodiments provide a seat connecting device with an adjustable backrest, belonging to the technical field of swivel chairs. In the embodiments, the seat connecting device includes a seat back tightness control assembly including a control handle, a universal joint, a transmission rod, a first bevel gear, a second bevel gear, a lifting part, a mounting seat of the lifting part, and a tightness adjust rod.
    Type: Grant
    Filed: June 12, 2020
    Date of Patent: September 12, 2023
    Assignee: Anji Deka Office System Co., Ltd.
    Inventors: Zhenlin Meng, Chiachi Shu, Bin Zheng, Wenyuan Pan, Kun Yang
  • Patent number: D1006100
    Type: Grant
    Filed: September 19, 2022
    Date of Patent: November 28, 2023
    Assignee: Falcon Innovations Technology (Shenzhen) Co., Ltd
    Inventors: Bin Zheng, Gang Xu, Mingjie Wang
  • Patent number: D1006866
    Type: Grant
    Filed: September 19, 2022
    Date of Patent: December 5, 2023
    Assignee: Falcon Innovations Technology (Shenzhen) Co., Ltd.
    Inventors: Bin Zheng, Mingjie Wang